Translational Research Institute (Australia)
The Translational Research Institute
|
|
| Founder(s) | Professor Ian Frazer AC |
|---|---|
| Established | October 2013 |
| Mission | Medical research |
| Focus | Translational |
| Chief Executive Officer | Carolyn Mountford |
| Faculty | |
| Adjunct faculty | Brisbane Diamantina Health Partners |
| Staff | 650 |
| Location | Kent Street, Woolloongabba, Brisbane, Queensland, Australia |
| Website | www |
The Translational Research Institute (TRI) is Australia’s first translational medical research institute dedicated to translating scientific discoveries into applications for medical practice.
Located in Woolloongabba, in inner-city Brisbane, Queensland, TRI is supported by a grant from the Australian Government ($140 million); and funding from the Queensland Government ($107 million); The Atlantic Philanthropies ($50 million); Queensland University of Technology ($25 million); and The University of Queensland ($10 million) to combine clinical and translational research to advance progress from laboratory discovery to application in patient care.
The institute combines academic medicine and translational research, in order to minimise the time between a laboratory discovery and its effective application in the clinic and the community. To further this goal, the TRI is a member of the Brisbane Diamantina Health Partners, Queensland's first academic health science system.
In 2004 a proposal was submitted to the Queensland Government for the development and construction of TRI. In 2007 this progressed to project design. Five years on and A$354 million in funding from the Australian and Queensland Governments, The Atlantic Philanthropies, UQ and QUT, TRI became operational and four institutes came together. TRI was officially opened in October 2013 by the Governor-General Dame Quentin Bryce.
...
Wikipedia